Elizabeta C. Popa

Oncology
1305 York Ave Fl 12
New York, NY 10021

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Corrigendum to "Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events" [Pathol. - Res. Pract. 266 (2025) 155798].

Corrigendum to "Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events" [Pathol. - Res. Pract. 266 (2025) 155798].

Journal: Pathology, research and practice
Published: February 01, 2025

Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events.

Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events.

Journal: Pathology, research and practice
Published: December 19, 2024

Spectrum of Findings Seen in Patients With IDH1/2-Mutant Cholangiocarcinoma.

Spectrum of Findings Seen in Patients With IDH1/2-Mutant Cholangiocarcinoma.

Journal: International journal of surgical pathology
Published: September 24, 2024

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.

Journal: Oncogene
Published: August 23, 2023

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 31, 2020

Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms.

Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms.

Journal: Current gastroenterology reports
Published: August 16, 2020

A pilot study treatment of malignant tumors using low-dose 18F-fluorodeoxyglucose (18F-FDG).

A pilot study treatment of malignant tumors using low-dose 18F-fluorodeoxyglucose (18F-FDG).

Journal: American journal of nuclear medicine and molecular imaging
Published: June 23, 2020

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2016

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Journal: Cancer
Published: April 14, 2016

Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis.

Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 02, 2015

The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.

The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.

Journal: Current treatment options in oncology
Published: July 28, 2014

Capecitabine in the treatment of esophageal and gastric cancers.

Capecitabine in the treatment of esophageal and gastric cancers.

Journal: Expert opinion on investigational drugs
Published: October 05, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026